Applied Biosciences Stock Forecast, Price & News

0.00 (0.00 %)
(As of 06/11/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume3,488 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive APPB News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Applied Biosciences logo

About Applied Biosciences

Applied Biosciences Corp. focuses on the development and commercialization of novel, synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It is focused on investment and partnership opportunities under the Applied BioSciences brand in the medical, scientific, nutraceutical, and health and wellness markets. The company also produces health and wellness products, including creams, balms, tinctures, concentrates, and edibles under the Remedi, Remedi Plus, Herbal Pet, MTN CBD, Champ Organics, and Equine Care names. It focuses on various areas of the medical, scientific, bioceutical, hemp, and CBD industry. In addition, the company provides lab testing services. It delivers consumer and OTC THC-free CBD products to its customers in the United States and internationally. Applied Biosciences Corp. was incorporated in 2014 and is based in New York, New York.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.52 out of 5 stars

Medical Sector

1580th out of 2,100 stocks

Drug Manufacturers - Specialty & Generic Industry

41st out of 60 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Applied Biosciences (OTCMKTS:APPB) Frequently Asked Questions

What stocks does MarketBeat like better than Applied Biosciences?

Wall Street analysts have given Applied Biosciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Applied Biosciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Applied Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Applied Biosciences' stock was trading at $0.4350 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, APPB stock has decreased by 95.4% and is now trading at $0.02.
View which stocks have been most impacted by COVID-19

Who are Applied Biosciences' key executives?

Applied Biosciences' management team includes the following people:
  • Mr. Christopher Michael Bridges, Pres & Director (Age 42)
  • Mr. Scott B. Stevens, Founder & Chairman (Age 44)
  • Mr. David Fiene, Controller (Age 50)

Who are some of Applied Biosciences' key competitors?

What other stocks do shareholders of Applied Biosciences own?

What is Applied Biosciences' stock symbol?

Applied Biosciences trades on the OTCMKTS under the ticker symbol "APPB."

How do I buy shares of Applied Biosciences?

Shares of APPB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied Biosciences' stock price today?

One share of APPB stock can currently be purchased for approximately $0.02.

How many employees does Applied Biosciences have?

Applied Biosciences employs 25 workers across the globe.

What is Applied Biosciences' official website?

The official website for Applied Biosciences is www.appliedbiocorp.com.

How can I contact Applied Biosciences?

The company can be reached via phone at 310-356-7374.

This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.